Balance Sheet
Accounts PayablesAccumulated ExpensesCommon EquityConvertible DebtLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicale (MCLE) Common Equity (2020 - 2025)

Medicale's Common Equity history spans 6 years, with the latest figure at -$129416.0 for Q2 2025.

  • For Q2 2025, Common Equity fell 57.72% year-over-year to -$129416.0; the TTM value through Jun 2025 reached -$129416.0, down 57.72%, while the annual FY2024 figure was -$98933.0, 142.96% down from the prior year.
  • Common Equity reached -$129416.0 in Q2 2025 per MCLE's latest filing, down from -$123888.0 in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5108.0 in Q1 2021 to a low of -$129416.0 in Q2 2025.
  • Average Common Equity over 5 years is -$52195.3, with a median of -$40570.0 recorded in 2022.
  • The largest YoY upside for Common Equity was 56.23% in 2022 against a maximum downside of 2135.62% in 2022.
  • A 5-year view of Common Equity shows it stood at -$27051.0 in 2021, then soared by 56.23% to -$11841.0 in 2022, then crashed by 406.94% to -$60027.0 in 2023, then plummeted by 92.6% to -$115613.0 in 2024, then dropped by 11.94% to -$129416.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Common Equity are -$129416.0 (Q2 2025), -$123888.0 (Q1 2025), and -$115613.0 (Q4 2024).